More recent hepatobiliary focussed publications identified mutations in Sema7a causing a gain of function, progressing disease; non-alcoholic fatty liver disease (NAFLD) and intrahepatic cholestasis [54, 57]. Here, SEMA7A is linked to intrahepatic cholestasis.